APA

van der Kamp H. J., Oudshoorn C. G. M., Elvers B. H., van Baarle M., Otten B. J., Wit J. M. & Verkerk P. H. (20050809). Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. : The Journal of clinical endocrinology and metabolism.

Chicago

van der Kamp Hetty J, Oudshoorn Caren G M, Elvers Bert H, van Baarle Maja, Otten Barto J, Wit Jan M and Verkerk Paul H. 20050809. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. : The Journal of clinical endocrinology and metabolism.

Harvard

van der Kamp H. J., Oudshoorn C. G. M., Elvers B. H., van Baarle M., Otten B. J., Wit J. M. and Verkerk P. H. (20050809). Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. : The Journal of clinical endocrinology and metabolism.

MLA

van der Kamp Hetty J, Oudshoorn Caren G M, Elvers Bert H, van Baarle Maja, Otten Barto J, Wit Jan M and Verkerk Paul H. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. : The Journal of clinical endocrinology and metabolism. 20050809.